Pub Date : 2026-01-07eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1689146
Christine L Bokman, Roy P Yu, Shaili S Davuluru, Rasika Sudharshan, Kristen E Park, Sarah Guo, Joy Li, Preeya Mehta, Alice Shen, Jessica R Chang, Alex K Wong, Young-Kwon Hong, Sandy X Zhang-Nunes
Purpose: We sought to investigate whether variations in lymphatic morphology are associated with postoperative eyelid edema in patients who underwent upper eyelid blepharoplasty.
Methods: This was a prospective study in which nine upper eyelid skin samples were stained with Podoplanin to immunochemically mark lymphatic vessels. Lymphatic vessel area, density, and perimeter were calculated from averaging 38 slices across 3 cuts of eyelid skin. Corresponding postoperative patient photographs were graded by four physicians with a standardized postoperative edema grading scale that ranged from zero (no edema) to three (severe edema). Patients were classified as having clinically significant eyelid edema (CSEE) if they received an edema grade greater than zero 90 days postoperatively or a grade of three at any time point.
Results: Anti-podoplanin staining demonstrated that there was significantly lower lymphatic vessel density among patients with severe edema (8.00 ± 1.67 vessels/mm2) compared to patients with mild or no edema (12.14 ± 1.93 vessels/mm2, p < 0.05). Lymphatic vessel area and perimeter did not reveal any significant associations with postoperative edema grades.
Conclusions: In patients undergoing an upper eyelid blepharoplasty, severe postoperative swelling was significantly associated with lower lymphatic vessel density, but not with lymphatic vessel area or perimeter. These findings suggest that the lymphatic network of the eyelid could play a role in the degree of postoperative swelling.
目的:我们试图研究淋巴形态的变化是否与上睑成形术患者术后眼睑水肿有关。方法:这是一项前瞻性研究,用Podoplanin染色上眼睑皮肤样本,免疫化学标记淋巴管。淋巴管的面积、密度和周长由眼睑皮肤3个切口平均38片计算得到。相应的术后患者照片由四位医生用标准化的术后水肿分级量表评分,评分范围从0(无水肿)到3(严重水肿)。如果患者术后90天的水肿等级大于0或在任何时间点的水肿等级为3,则将其归类为具有临床显著性眼睑水肿(CSEE)。结果:抗podoplanin染色显示,重度水肿患者的淋巴管密度(8.00±1.67支/mm2)明显低于轻度或无水肿患者(12.14±1.93支/mm2, p < 0.05)。淋巴管面积和周长与术后水肿程度没有明显的相关性。结论:在接受上睑成形术的患者中,术后严重肿胀与淋巴管密度降低显著相关,但与淋巴管面积或周长无关。这些发现表明,眼睑的淋巴网络可能在术后肿胀程度中起作用。
{"title":"Association of decreased lymphatic vessel density with postoperative eyelid edema.","authors":"Christine L Bokman, Roy P Yu, Shaili S Davuluru, Rasika Sudharshan, Kristen E Park, Sarah Guo, Joy Li, Preeya Mehta, Alice Shen, Jessica R Chang, Alex K Wong, Young-Kwon Hong, Sandy X Zhang-Nunes","doi":"10.3389/fopht.2025.1689146","DOIUrl":"10.3389/fopht.2025.1689146","url":null,"abstract":"<p><strong>Purpose: </strong>We sought to investigate whether variations in lymphatic morphology are associated with postoperative eyelid edema in patients who underwent upper eyelid blepharoplasty.</p><p><strong>Methods: </strong>This was a prospective study in which nine upper eyelid skin samples were stained with Podoplanin to immunochemically mark lymphatic vessels. Lymphatic vessel area, density, and perimeter were calculated from averaging 38 slices across 3 cuts of eyelid skin. Corresponding postoperative patient photographs were graded by four physicians with a standardized postoperative edema grading scale that ranged from zero (no edema) to three (severe edema). Patients were classified as having clinically significant eyelid edema (CSEE) if they received an edema grade greater than zero 90 days postoperatively or a grade of three at any time point.</p><p><strong>Results: </strong>Anti-podoplanin staining demonstrated that there was significantly lower lymphatic vessel density among patients with severe edema (8.00 ± 1.67 vessels/mm<sup>2</sup>) compared to patients with mild or no edema (12.14 ± 1.93 vessels/mm<sup>2</sup>, <i>p</i> < 0.05). Lymphatic vessel area and perimeter did not reveal any significant associations with postoperative edema grades.</p><p><strong>Conclusions: </strong>In patients undergoing an upper eyelid blepharoplasty, severe postoperative swelling was significantly associated with lower lymphatic vessel density, but not with lymphatic vessel area or perimeter. These findings suggest that the lymphatic network of the eyelid could play a role in the degree of postoperative swelling.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1689146"},"PeriodicalIF":0.9,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12819238/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146031811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-07eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1724513
Carmelo Caltabiano, Khizar Rana, Alexander Buckby, Sandy Patel, Dinesh Selva
Lacrimal gland masses represent a diverse group of pathological processes, including inflammatory, lymphoproliferative, and neoplastic lesions. They often present as a palpable mass in the superolateral orbit. There is significant overlap in clinical presentation, and imaging with ultrasound, computed tomography, and magnetic resonance imaging is essential for further characterisation. Key radiological features such as laterality, lobe involvement, lesion composition, margin definition, enhancement pattern, and associated bony changes can significantly narrow the differential diagnosis. This review will describe the radiological features of lacrimal gland masses to guide decision-making.
{"title":"Imaging features of lacrimal gland disease.","authors":"Carmelo Caltabiano, Khizar Rana, Alexander Buckby, Sandy Patel, Dinesh Selva","doi":"10.3389/fopht.2025.1724513","DOIUrl":"10.3389/fopht.2025.1724513","url":null,"abstract":"<p><p>Lacrimal gland masses represent a diverse group of pathological processes, including inflammatory, lymphoproliferative, and neoplastic lesions. They often present as a palpable mass in the superolateral orbit. There is significant overlap in clinical presentation, and imaging with ultrasound, computed tomography, and magnetic resonance imaging is essential for further characterisation. Key radiological features such as laterality, lobe involvement, lesion composition, margin definition, enhancement pattern, and associated bony changes can significantly narrow the differential diagnosis. This review will describe the radiological features of lacrimal gland masses to guide decision-making.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1724513"},"PeriodicalIF":0.9,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12819838/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146031859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-07eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1689724
Lisa Brothers Arbisser
The state of the art of in-the-bag cataract surgery, though one of the most successful surgeries in ophthalmology, has significant room for improvement as a one-time, lifetime solution for optical clarity. Though optic capture techniques have been known since the 1990's they are underutilized and not adequately explored or understood. This perspective not only explains their history and value but also clarifies the anatomy and suggests a proven improvement and a proposed study for another solution: hyaloid sparing double capture, to once again elevate the outcomes and lessen the complications of our routine surgery. Open your mind: hone your skills with this knowledge and help us move forward.
{"title":"Introducing hyaloid-sparing double capture: a novel technique in cataract surgery-anticipated clinical trial rationale and invitation.","authors":"Lisa Brothers Arbisser","doi":"10.3389/fopht.2025.1689724","DOIUrl":"10.3389/fopht.2025.1689724","url":null,"abstract":"<p><p>The state of the art of in-the-bag cataract surgery, though one of the most successful surgeries in ophthalmology, has significant room for improvement as a one-time, lifetime solution for optical clarity. Though optic capture techniques have been known since the 1990's they are underutilized and not adequately explored or understood. This perspective not only explains their history and value but also clarifies the anatomy and suggests a proven improvement and a proposed study for another solution: hyaloid sparing double capture, to once again elevate the outcomes and lessen the complications of our routine surgery. Open your mind: hone your skills with this knowledge and help us move forward.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1689724"},"PeriodicalIF":0.9,"publicationDate":"2026-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12819183/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146031873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-06eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1660483
Mariam M AlEissa, Malak Abedalthagafi, Deepak P Edward
Consanguineous marriages are common, particularly in Saudi Arabia, where approximately half of all marriages are consanguineous. The likelihood of autosomal recessive (AR) genetic abnormalities, especially rare diseases (RDs) that present long-term health issues, is significantly increased by this trend, making Inherited Ocular Diseases (IODs) a public health concern in Saudi Arabia. The common IODs include Primary Congenital Glaucoma (PCG), Retinitis Pigmentosa (RP), and Leber Congenital Amaurosis (LCA). To date, there are no national initiatives for screening programs to detect, prevent, and manage IOD. This review aims to evaluate the public health landscape of IOD in Saudi Arabia, including epidemiology and genetic factors. It highlights the need for a national framework to facilitate screening, prevention, and early intervention. Cost-effectiveness evaluation, early genetic screening, and counseling can drastically lower the long-term medical expenses related to IOD management. Outreach programs can be used to address issues, including cultural acceptance and equitable access to screening services, which are needed. Further carrier screening for at-risk families accompanied by genetic counseling decreases new IOD cases and provides better family planning for impacted populations. These are among the expected results, which will eventually enhance health outcomes and ensure the long-term viability of Saudi Arabia's healthcare system. In alignment with Vision 2030's futuristic pipeline for screening, introducing telemedicine and AI-driven predictive tools can enhance accessibility and precision in screening programs.
{"title":"Prevention and early intervention screening for inherited ocular diseases in Saudi Arabia: a national perspective.","authors":"Mariam M AlEissa, Malak Abedalthagafi, Deepak P Edward","doi":"10.3389/fopht.2025.1660483","DOIUrl":"10.3389/fopht.2025.1660483","url":null,"abstract":"<p><p>Consanguineous marriages are common, particularly in Saudi Arabia, where approximately half of all marriages are consanguineous. The likelihood of autosomal recessive (AR) genetic abnormalities, especially rare diseases (RDs) that present long-term health issues, is significantly increased by this trend, making Inherited Ocular Diseases (IODs) a public health concern in Saudi Arabia. The common IODs include Primary Congenital Glaucoma (PCG), Retinitis Pigmentosa (RP), and Leber Congenital Amaurosis (LCA). To date, there are no national initiatives for screening programs to detect, prevent, and manage IOD. This review aims to evaluate the public health landscape of IOD in Saudi Arabia, including epidemiology and genetic factors. It highlights the need for a national framework to facilitate screening, prevention, and early intervention. Cost-effectiveness evaluation, early genetic screening, and counseling can drastically lower the long-term medical expenses related to IOD management. Outreach programs can be used to address issues, including cultural acceptance and equitable access to screening services, which are needed. Further carrier screening for at-risk families accompanied by genetic counseling decreases new IOD cases and provides better family planning for impacted populations. These are among the expected results, which will eventually enhance health outcomes and ensure the long-term viability of Saudi Arabia's healthcare system. In alignment with Vision 2030's futuristic pipeline for screening, introducing telemedicine and AI-driven predictive tools can enhance accessibility and precision in screening programs.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1660483"},"PeriodicalIF":0.9,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12815791/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-19eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1749411
Kevin Williams-Gaona, Rosa Corro
{"title":"Commentary: Synergistic AI-resident approach achieves superior diagnostic accuracy in tertiary ophthalmic care for glaucoma and retinal disease.","authors":"Kevin Williams-Gaona, Rosa Corro","doi":"10.3389/fopht.2025.1749411","DOIUrl":"10.3389/fopht.2025.1749411","url":null,"abstract":"","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1749411"},"PeriodicalIF":0.9,"publicationDate":"2025-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12757209/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145901791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-18eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1743468
Małgorzata B Różanowska, Jennifer J Hunter
{"title":"Editorial: Diagnostic and therapeutic applications of visible and near-infrared light for the retina.","authors":"Małgorzata B Różanowska, Jennifer J Hunter","doi":"10.3389/fopht.2025.1743468","DOIUrl":"10.3389/fopht.2025.1743468","url":null,"abstract":"","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1743468"},"PeriodicalIF":0.9,"publicationDate":"2025-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12756143/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145901765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-16eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1628665
Po-Yu Tsai, Hui-Chen Su, Yu-Ming Chang
Background: Trigeminal autonomic cephalalgias (TACs) are characterized by unilateral headache with cranial autonomic symptoms. Sudden subtype changes may suggest secondary causes.
Case presentation: A 66-year-old woman presented with a rapid shift from paroxysmal hemicrania to SUNCT. Varicella zoster virus (VZV) reactivation was confirmed by CSF analysis and aqueous humor PCR. Ocular involvement included panuveitis and papillitis. Symptoms resolved after 14 days of intravenous acyclovir.
Conclusion: Rapid TACs subtype transformation should prompt evaluation for secondary causes. Early diagnosis of VZV can lead to favorable outcomes.
{"title":"From paroxysmal hemicrania to SUNCT: a unique presentation of herpetic zoster ophthalmicus: a case report.","authors":"Po-Yu Tsai, Hui-Chen Su, Yu-Ming Chang","doi":"10.3389/fopht.2025.1628665","DOIUrl":"10.3389/fopht.2025.1628665","url":null,"abstract":"<p><strong>Background: </strong>Trigeminal autonomic cephalalgias (TACs) are characterized by unilateral headache with cranial autonomic symptoms. Sudden subtype changes may suggest secondary causes.</p><p><strong>Case presentation: </strong>A 66-year-old woman presented with a rapid shift from paroxysmal hemicrania to SUNCT. Varicella zoster virus (VZV) reactivation was confirmed by CSF analysis and aqueous humor PCR. Ocular involvement included panuveitis and papillitis. Symptoms resolved after 14 days of intravenous acyclovir.</p><p><strong>Conclusion: </strong>Rapid TACs subtype transformation should prompt evaluation for secondary causes. Early diagnosis of VZV can lead to favorable outcomes.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1628665"},"PeriodicalIF":0.9,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12747899/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145879530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-16eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1691372
Diego Strianese, Claudio Barbato, Mario Troisi, Vittoria Lanni, Vincenzo Damiano, Rosa Maria Di Crescenzo, Maria Laura Passaro, Antonella D'Aponte, Raffaele Nubi, Manuel Conson, Dana Cohen, Giuseppe Mariniello, Ciro Costagliola, Adriana Iuliano
Background: Merkel cell carcinoma (MCC) of the eyelid is rare and aggressive. Diagnostic delay and inadequate excision may promote early nodal spread. We assessed the influence of surgical margins and re-excision timing on outcomes, supported by a PRISMA-guided systematic review on metastatic risk.
Methods: A single-center retrospective series (2012-2024) included 9 histologically confirmed eyelid MCCs, analyzing presentation, treatment, and outcomes. Surgical strategies were classified as one-step wide local excision (1WLE, ≥5 mm), two-step wide local excision (2WLE) with early (E2WLE, ≤2 months) or late (L2WLE, 6 months) re-excision, and insufficient margin excision (IME, <2 mm without re-excision). A systematic review identified periocular MCC cases with individual-level data on margins and outcomes.
Results: Patients (median age 71.8 years, range 42-92; 89% female) all presented with solitary nodules on the upper eyelid, and were node-negative and metastasis-free at diagnosis, consistent with AJCC 8th clinical stage I-IIA.Median follow-up was 48 months (IQR 12-120). Treatments included 1WLE (n=4), 2WLE (n=3; 2 E2WLE, 1 L2WLE), and IME (n=2). Three patients (33%) developed cervical lymph node metastases within 1-3 months: one after L2WLE (fatal at 12 months) and two after IME. Both IME patients showed marked responses to Avelumab. Of the remaining six, four (67%) remained disease-free and two (33%) died of unrelated causes. Metastatic risk was significantly higher after IME versus sufficient margins (p=0.0119). In the PRISMA-guided review (76 eyelid MCC), insufficient margins correlated with adverse outcomes; in a subset without baseline metastasis (n=39), insufficient margins increased risk of recurrence/metastasis (OR 10.56; 95% CI 1.84-77.24; Fisher's exact p=0.002).
Conclusion: In eyelid MCC, adequate margins at first surgery or early re-excision are crucial to prevent early nodal spread. Our findings emphasize the prognostic value of surgical adequacy and support incorporating wide excision into initial management. Further multicenter studies are warranted to define evidence-based management pathways, improve long-term outcomes, and clarify the role of checkpoint inhibition in periocular MCC.
{"title":"Optimizing surgical margins in the treatment of eyelid Merkel cell carcinoma: a tertiary center experience and literature review.","authors":"Diego Strianese, Claudio Barbato, Mario Troisi, Vittoria Lanni, Vincenzo Damiano, Rosa Maria Di Crescenzo, Maria Laura Passaro, Antonella D'Aponte, Raffaele Nubi, Manuel Conson, Dana Cohen, Giuseppe Mariniello, Ciro Costagliola, Adriana Iuliano","doi":"10.3389/fopht.2025.1691372","DOIUrl":"10.3389/fopht.2025.1691372","url":null,"abstract":"<p><strong>Background: </strong>Merkel cell carcinoma (MCC) of the eyelid is rare and aggressive. Diagnostic delay and inadequate excision may promote early nodal spread. We assessed the influence of surgical margins and re-excision timing on outcomes, supported by a PRISMA-guided systematic review on metastatic risk.</p><p><strong>Methods: </strong>A single-center retrospective series (2012-2024) included 9 histologically confirmed eyelid MCCs, analyzing presentation, treatment, and outcomes. Surgical strategies were classified as one-step wide local excision (1WLE, ≥5 mm), two-step wide local excision (2WLE) with early (E2WLE, ≤2 months) or late (L2WLE, 6 months) re-excision, and insufficient margin excision (IME, <2 mm without re-excision). A systematic review identified periocular MCC cases with individual-level data on margins and outcomes.</p><p><strong>Results: </strong>Patients (median age 71.8 years, range 42-92; 89% female) all presented with solitary nodules on the upper eyelid, and were node-negative and metastasis-free at diagnosis, consistent with AJCC 8th clinical stage I-IIA.Median follow-up was 48 months (IQR 12-120). Treatments included 1WLE (n=4), 2WLE (n=3; 2 E2WLE, 1 L2WLE), and IME (n=2). Three patients (33%) developed cervical lymph node metastases within 1-3 months: one after L2WLE (fatal at 12 months) and two after IME. Both IME patients showed marked responses to Avelumab. Of the remaining six, four (67%) remained disease-free and two (33%) died of unrelated causes. Metastatic risk was significantly higher after IME versus sufficient margins (p=0.0119). In the PRISMA-guided review (76 eyelid MCC), insufficient margins correlated with adverse outcomes; in a subset without baseline metastasis (n=39), insufficient margins increased risk of recurrence/metastasis (OR 10.56; 95% CI 1.84-77.24<b>;</b> Fisher's exact p=0.002).</p><p><strong>Conclusion: </strong>In eyelid MCC, adequate margins at first surgery or early re-excision are crucial to prevent early nodal spread. Our findings emphasize the prognostic value of surgical adequacy and support incorporating wide excision into initial management. Further multicenter studies are warranted to define evidence-based management pathways, improve long-term outcomes, and clarify the role of checkpoint inhibition in periocular MCC.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1691372"},"PeriodicalIF":0.9,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12747939/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145879587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-15eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1671266
Diana Joseph, Brian Grover, Michael Telias
The vitreous fluid, situated in the posterior chamber of the eye, holds a close relationship with the inner retina. Within this milieu, retinal cells secrete a diverse array of biomolecules, potentially harboring vital biomarkers. Among these, short, non-coding micro-RNAs (miRNAs) emerge as promising candidates. Their dynamic regulation by various gene signaling mechanisms, enhanced resistance to degradation, and secretion via separate exocytotic pathways make them particularly significant. Alterations in vitreal miRNA profiles may reflect pathological states and offer insights into disease etiology and progression. Here, we conducted a comprehensive survey of 22 peer-reviewed studies to assess the potential of vitreous miRNAs as biomarkers for retinal diseases. Our analysis demonstrates the utility of miRNAs as biomarkers in specific retinal pathologies. We show that miR-142, miR-9, and miR-21 are robust biomarker candidates, displaying consistent and significant alterations correlating with proliferative vitreoretinal diseases. We also address the methodological challenges encountered in characterizing vitreous miRNA content, including the absence of standardized purification, amplification, and analysis protocols, as well as the scarcity of true control samples. Moreover, we recommend the adoption of specific housekeeping genes and data normalization techniques to standardize miRNA analysis in the vitreous and explore potential methodologies for obtaining vitreous samples from healthy individuals. We conclude that vitreous miRNAs hold promise as potential biomarkers for various retinal diseases, with miR-142, miR-9, and miR-21 emerging as promising candidates. Enhancing methodologies for vitreous sampling and miRNA analysis presents an opportunity to expand the repertoire and utility of miRNA biomarkers in retinal disease diagnosis and prognosis.
{"title":"Systematic review on biomarker potential of vitreous microRNA in retinal disease.","authors":"Diana Joseph, Brian Grover, Michael Telias","doi":"10.3389/fopht.2025.1671266","DOIUrl":"10.3389/fopht.2025.1671266","url":null,"abstract":"<p><p>The vitreous fluid, situated in the posterior chamber of the eye, holds a close relationship with the inner retina. Within this milieu, retinal cells secrete a diverse array of biomolecules, potentially harboring vital biomarkers. Among these, short, non-coding micro-RNAs (miRNAs) emerge as promising candidates. Their dynamic regulation by various gene signaling mechanisms, enhanced resistance to degradation, and secretion via separate exocytotic pathways make them particularly significant. Alterations in vitreal miRNA profiles may reflect pathological states and offer insights into disease etiology and progression. Here, we conducted a comprehensive survey of 22 peer-reviewed studies to assess the potential of vitreous miRNAs as biomarkers for retinal diseases. Our analysis demonstrates the utility of miRNAs as biomarkers in specific retinal pathologies. We show that miR-142, miR-9, and miR-21 are robust biomarker candidates, displaying consistent and significant alterations correlating with proliferative vitreoretinal diseases. We also address the methodological challenges encountered in characterizing vitreous miRNA content, including the absence of standardized purification, amplification, and analysis protocols, as well as the scarcity of true control samples. Moreover, we recommend the adoption of specific housekeeping genes and data normalization techniques to standardize miRNA analysis in the vitreous and explore potential methodologies for obtaining vitreous samples from healthy individuals. We conclude that vitreous miRNAs hold promise as potential biomarkers for various retinal diseases, with miR-142, miR-9, and miR-21 emerging as promising candidates. Enhancing methodologies for vitreous sampling and miRNA analysis presents an opportunity to expand the repertoire and utility of miRNA biomarkers in retinal disease diagnosis and prognosis.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1671266"},"PeriodicalIF":0.9,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12745263/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145866779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-15eCollection Date: 2025-01-01DOI: 10.3389/fopht.2025.1754941
Evangelos Anagnostou, Georgios Armenis
Eye movement abnormalities are increasingly recognized as early and sensitive markers of neurodegenerative dementias, particularly Alzheimer's disease (AD). Disruptions in saccadic, antisaccadic, smooth pursuit, fixation, and naturalistic eye movement tasks reflect dysfunction in frontal, parietal, subcortical, and cerebellar circuits that are vulnerable to neurodegeneration. Studies have consistently demonstrated that AD patients show prolonged saccadic latencies, increased antisaccade error rates, reduced smooth pursuit gain, and fixation instability. Such deficits correlate with cognitive impairment, disease severity, and neuroimaging biomarkers of cortical atrophy. Comparisons with frontotemporal dementia (FTD), dementia with Lewy bodies (DLB), and posterior cortical atrophy (PCA) highlight overlapping yet distinct oculomotor profiles, suggesting diagnostic and prognostic value. Eye-tracking methodologies offer non-invasive, cost-effective tools that could complement neuropsychological and imaging assessments. However, methodological variability remains a barrier to clinical implementation. This review integrates evidence from foundational and recent studies to provide a comprehensive account of oculomotor dysfunction in AD and other dementias, emphasizing the translational potential of eye movement biomarkers in clinical practice and research.
{"title":"Eye movement abnormalities in Alzheimer's disease and other neurodegenerative dementias: insights from current evidence and priorities for future research.","authors":"Evangelos Anagnostou, Georgios Armenis","doi":"10.3389/fopht.2025.1754941","DOIUrl":"10.3389/fopht.2025.1754941","url":null,"abstract":"<p><p>Eye movement abnormalities are increasingly recognized as early and sensitive markers of neurodegenerative dementias, particularly Alzheimer's disease (AD). Disruptions in saccadic, antisaccadic, smooth pursuit, fixation, and naturalistic eye movement tasks reflect dysfunction in frontal, parietal, subcortical, and cerebellar circuits that are vulnerable to neurodegeneration. Studies have consistently demonstrated that AD patients show prolonged saccadic latencies, increased antisaccade error rates, reduced smooth pursuit gain, and fixation instability. Such deficits correlate with cognitive impairment, disease severity, and neuroimaging biomarkers of cortical atrophy. Comparisons with frontotemporal dementia (FTD), dementia with Lewy bodies (DLB), and posterior cortical atrophy (PCA) highlight overlapping yet distinct oculomotor profiles, suggesting diagnostic and prognostic value. Eye-tracking methodologies offer non-invasive, cost-effective tools that could complement neuropsychological and imaging assessments. However, methodological variability remains a barrier to clinical implementation. This review integrates evidence from foundational and recent studies to provide a comprehensive account of oculomotor dysfunction in AD and other dementias, emphasizing the translational potential of eye movement biomarkers in clinical practice and research.</p>","PeriodicalId":73096,"journal":{"name":"Frontiers in ophthalmology","volume":"5 ","pages":"1754941"},"PeriodicalIF":0.9,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12745221/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145866712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}